Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hutchinson validates StO2 monitor in trauma setting:

This article was originally published in Clinica

Executive Summary

Hutchinson Technology says that a clinical trial has confirmed the value of using its noninvasive InSpectra tissue oxygen saturation (StO2) monitor in trauma patients. Local StO2 measured by the near infrared spectroscopy-based monitor on the muscle at the base of the thumb was a statistically significant indicator of inadequate blood flow in trauma patients, revealed the study of 383 severely injured people. InSpectra was cleared for sale in the US in July this year. Shipments of the device are expected to begin by the end of 2006, says the Hutchinson, Minnesota firm. The technology is indicated for use in monitoring patients during circulatory or perfusion examinations of skeletal muscle, or when there is a suspicion of compromised circulation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT053222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel